Selma Medical Associates
Winchester, Virginia, United States
Medical center in Winchester, Virginia
104 Selma Dr, Winchester, VA 22601
About Selma Medical Associates
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
American Regent, Inc.
1
Amgen
1
Bayer
1
Eisai Inc.
1
Janssen Research & Development, LLC
1
Pfizer
1
Clinical Trials at Selma Medical Associates
During the past decade, Selma Medical Associates conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
2013-10-29
2017-07-10
Completed
2,139
A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors
2014-01-24
2018-05-14
Completed
14,673
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
2017-03-15
2023-06-01
Active, not recruiting
3,068
Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke
2019-06-11
2025-07-26
Active, not recruiting
12,301
Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone on Morbidity (Events Indicating Disease Worsening) & Mortality (Death Rate) in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40%
2020-09-14
2024-09-13
Active, not recruiting
6,016
A Study of Vaccination With 9-valent Extraintestinal Pathogenic Escherichia Coli Vaccine (ExPEC9V) in the Prevention of Invasive Extraintestinal Pathogenic Escherichia Coli Disease in Adults Aged 60 Years And Older With a History of Urinary Tract Infection in the Past 2 Years
2021-06-30
2028-05-14
Recruiting
18,556
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Selma Medical Associates" #1 sponsor was "American Regent, Inc." with 1 trials, followed by "Amgen" with 1 trials
sponsored, "Bayer" with 1 trials sponsored, "Eisai Inc." with 1 trials sponsored and "Janssen Research & Development, LLC"
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Selma Medical Associates"
#1 collaborator was "Duke Clinical Research Institute" with 1 trials as a collaborator and "Thrombolysis In Myocardial Infarction (TIMI) Academic Research Organization" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Selma Medical Associates
According to Clinical.Site data, the most researched conditions in "Selma Medical Associates" are
"Heart Failure" (2 trials), "Cardiovascular Disease" (1 trials), "Coronary Heart Disease (CHD)" (1 trials), "High Cardiovascular Risk" (1 trials) and "Hyperlipidemia" (1 trials). Many other conditions were trialed in "Selma Medical Associates" in a lesser frequency.
Clinical Trials Intervention Types at Selma Medical Associates
Most popular intervention types in "Selma Medical Associates" are "Drug" (5 trials), "Other" (3 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "Bococizumab (PF-04950615; RN316)" (1 trials), "Evolocumab" (1 trials), "ExPEC9V" (1 trials) and "Ferric Carboxymaltose" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Selma Medical Associates
The vast majority of trials in "Selma Medical Associates" are
6 trials for "All" genders.
Clinical Trials Status at Selma Medical Associates
Currently, there are NaN active trials in "Selma Medical Associates".
undefined are not yet recruiting,
1 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Selma Medical Associates,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Selma Medical Associates, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".